Clinical Trials Directory

Trials / Completed

CompletedNCT02053857

Pilot Study of PUFA-optimized RUTF for Severe Acute Malnutrition

A Randomized, Double-blind Pilot Study of Polyunsaturated Fatty Acid-optimized Ready-to-use Therapeutic Food, Compared to Standard RUTF, in the Therapy of Severe Acute Malnutrition

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
141 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
6 Months – 59 Months
Healthy volunteers
Not accepted

Summary

To test whether a ready-to-use therapeutic food (RUTF) enriched with polyunsaturated fatty acids (RUTF-P) is as effective for the treatment of severe acute malnutrition (SAM) as standard RUTF.

Detailed description

Since 2007, RUTF has been the recommended treatment for SAM. RUTF is not conducive to the growth of bacteria because of the low moisture content, does not require cooking, and has led to greater recovery rates than liquid milk formulations in direct comparisons. One expected benefit of the RUTF-P is improved outcomes due to the higher levels of essential fatty acids. The essential fatty acid profile (i.e., the level of omega-3 and omega-6 fatty acids) of RUTF-P may have important implications for cognitive development of children, especially infants, with SAM who consume these foods as their sole dietary source for several weeks. In particular, an excess of omega-6 fatty acids (from sources such as peanut and corn oil) and a minimum of omega-3 fatty acids (from sources like flax) may fail to support optimal cognitive development and neural function. In this prospective, double-blinded, randomized controlled clinical effectiveness trial, we will compare two RUTF products in the treatment of SAM to test the effects of the two different RUTF products on essential fatty acid status.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRUTF
DIETARY_SUPPLEMENTRUTF-P
DRUGAmoxicillin

Timeline

Start date
2014-02-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2014-02-04
Last updated
2014-09-29

Locations

1 site across 1 country: Malawi

Source: ClinicalTrials.gov record NCT02053857. Inclusion in this directory is not an endorsement.